Three-Drug attack on Tough-to-Treat cervical cancer
NCT ID NCT06654011
Summary
This study is testing a new combination of three drugs for women with a rare and aggressive type of cervical cancer that has spread, come back, or did not respond to prior treatment. The goal is to see if adding a new oral drug (IN10018) to two existing intravenous drugs can better control the cancer. Participants will receive the drug combination in cycles, and if it works, they will continue on a maintenance therapy to try to keep the cancer from growing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, 430000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Xiangyang Central Hospital
RECRUITINGXiangyang, Hubei, 441000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.